Articles

  • Jan 16, 2025 | mx.advfn.com | Byong H. Kim

    FiledPursuant to Rule 424(b)(3) RegistrationNo. 333-284172PROSPECTUSUpto 972,151 Shares of Common StockIssuable Upon Conversion of Shares of Series B Preferred StockUpto 303,041 Shares of Common StockIssuable Upon Conversion of Shares of Series C Preferred StockUpto 97,216 Shares of Common StockIssuable Upon Exercise of Placement Agent WarrantsLipellaPharmaceuticals Inc.

  • Jan 15, 2025 | ivoox.com | Tony Thai |Byong H. Kim

    Descripción de Will Norton This week, we’re talking to Will Norton, the founder and CEO of SimplyAgree, a platform that automates the administrative tasks of a closing—from signature packets to closing binders—so attorneys can focus on getting deals done for their clients. Will’s legal journey began in undergrad, where he double-majored in math and computer science while taking philosophy and history courses.

  • Jan 8, 2025 | ivoox.com | Tony Thai |Byong H. Kim

    Descripción de Denise Robinson Happy New Year! And welcome back to another year of Pioneers and Pathfinders!This week, we're joined by Denise Robinson, founding principal and Belonging & Well-Being Consultant at The Still Center, a consultancy that facilitates personal well-being, interpersonal connection, and organizational inclusion through mindfulness-based diversity and inclusion methods.

  • Jan 7, 2025 | ivoox.com | Tony Thai |Byong H. Kim

    Descripción de Eric Voogt Today we welcome Eric Voogt, the founder and CEO of PROOF, a legal tech company that connects law firms with independent process servers nationwide. Eric started as an engineer for an aircraft manufacturer, but left this profession to attend law school and pursue a career in law. In addition to his work at PROOF, he has been a partner at a Denver law firm for more than two decades.

  • Jan 6, 2025 | mx.advfn.com | Byong H. Kim

    Asfiled with the U.S. Securities and Exchange Commission on January 7, 2025RegistrationNo. 333–          UNITEDSTATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORMS-3REGISTRATION STATEMENTUNDER THESECURITIES ACT OF 1933LipellaPharmaceuticals Inc. (Exact name of registrant as specified in its charter) Delaware 20-2388040 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)LipellaPharmaceuticals Inc.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →